Geisinger Wyoming Valley Medical Center - Office of Clinical Research Operations

Geisinger

Bradycardia

Cardiomyopathies

Bundle-Branch Block

Psychological Burnout

Atrioventricular Block

Biotronik

Geisinger Health

condition

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

The purpose of the BIO-CONDUCT study is to demonstrate the safety and effectiveness of the BIOTRONIK Solia S pacing lead when implanted in the left bundle branch (LBB) area. Safety will be assessed by evaluating serious adverse device effects that occur through 3 months post-implant. Efficacy will be assessed by evaluating implant success rate.

BIOTRONIK Conduction System Pacing With the Solia Lead

Geisinger | Geisinger Wyoming Valley Medical Center - Office of Clinical Research Operations

Site insights

Work at this site?

Active trials

BIOTRONIK Conduction System Pacing With the Solia Lead (BIO-CONDUCT)

Trial sponsors